O-Substituted Serine Derivatives via Regioselective Cyclic Sulfamidates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing O-substituted serine derivatives suffer from limitations in regioselectivity, chemical yield, and optical purity, particularly when using aziridines, bases, trichloroacetimidates, or sulfamidates, resulting in restricted substituents and low yields.
Innovation Solution
A method involving the reaction of a cyclic sulfamidate derived from an amino acid derivative with an alcohol, utilizing specific cyclization and oxidation steps, achieves high regioselectivity and chemical yield while maintaining optical purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If aziridine derived from serine is used for producing O-substituted serine derivatives, then the reaction can proceed, but the regioselectivity of the reactive site is poor
Solution Approach 1:
The patent introduces a cyclic sulfamidate intermediate derived from serine as a mediator in the reaction pathway. This intermediate structure enables controlled regioselective reaction with alcohols to produce O-substituted serine derivatives with high regioselectivity, overcoming the poor site selectivity issue of direct aziridine reactions
2Productivity
If sulfamidate derived from serine is reacted with alcohol, then O-substituted serine derivatives can be produced, but the chemical yield is low
Solution Approach 1:
The patent optimizes reaction parameters including using specific bases (Cs2CO3, K2CO3), controlling reaction temperature (reflux conditions), and selecting appropriate solvents to significantly improve the chemical yield of O-substituted serine derivatives from the cyclic sulfamidate reaction, transforming a low-yield process into a high-yield synthesis method
3Manufacturing precision
If existing methods are used to produce O-substituted serine derivatives, then production can occur, but the optical purity is compromised
Solution Approach 1:
The patent employs preliminary protection of the amino group in serine before forming the cyclic sulfamidate intermediate. This preliminary action preserves the stereochemical integrity throughout the synthesis process, ensuring high optical purity in the final O-substituted serine derivatives while maintaining synthesis feasibility
4Adaptability or versatility
If direct alkyl incorporation into serine is performed, then O-alkyl substituted serine derivatives can be produced, but the substituent types are limited
Solution Approach 1:
The patent develops a universal cyclic sulfamidate intermediate that can react with various types of alcohols (primary, secondary, aromatic, aliphatic) to produce diverse O-substituted serine derivatives. This multi-functional approach significantly expands substituent diversity while maintaining reaction specificity through the controlled mechanism
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces O-substituted serine derivatives with improved regioselectivity, chemical yield, and optical purity, suitable for use in peptide pharmaceuticals and pharmaceutical intermediates.
Implementation Method 1
reacting the compound represented by general formula (IV), its chemically acceptable salt, or a solvate thereof with an oxidizing agent to obtain a compound represented by general formula (II)
Data Source
AI summary
It was discovered that a cyclic sulfamidate can be produced by reacting an amino acid derivative with a cyclization reagent. In addition, it was discovered that an O-substituted serine derivative can be produced by reacting a cyclic sulfamidate with an alcohol.